Description
Retatrutide is an investigational peptide reported in preclinical research as a multi-receptor agonist with activity at GLP-1, GIP, and glucagon receptors. With ≥99% purity confirmed by HPLC UV testing, Retatrutide is supplied as research-grade material for laboratory applications in metabolic studies.
Research Highlights (from published studies):
-
Evaluated in animal models for effects on food intake and appetite regulation
-
Investigated in preclinical settings for insulin sensitivity and glucose metabolism
-
Studied for its role in body weight dynamics and energy expenditure in laboratory models
-
Reported as a triple-agonist in comparative studies of metabolic pathways
Examples of Research Contexts:
-
Laboratory studies exploring obesity and metabolic dysfunction models
-
Experimental investigations in type 2 diabetes (T2D) research models
-
Preclinical comparisons of GLP-1 receptor agonism versus multi-agonist approaches
⚠️ Disclaimer: This product is intended strictly for laboratory research use only. It is not approved for human consumption, medical use, or dietary supplementation. Peptara does not claim safety, efficacy, or therapeutic outcomes in humans.